These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38584263)

  • 1. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
    Tian Y; Wang Y; Wen N; Wang S; Li B; Liu G
    BMC Cancer; 2024 Apr; 24(1):426. PubMed ID: 38584263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat hepatectomy justified in patients with early recurrence of colorectal cancer liver metastases: A systematic review and meta-analysis.
    Hellingman T; de Swart ME; Heymans MW; Jansma EP; van der Vliet HJ; Kazemier G
    Cancer Epidemiol; 2021 Oct; 74():101977. PubMed ID: 34303642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients.
    Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H
    Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
    Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
    Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value and prognostic factors of repeat hepatectomy for recurrent colorectal liver metastasis.
    Zhou JM; Wang L; Mao AR
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):570-576. PubMed ID: 36858891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
    Takeda K; Kikuchi Y; Sawada YU; Kumamoto T; Watanabe J; Kuniski C; Misumi T; Endo I
    Anticancer Res; 2022 Nov; 42(11):5497-5505. PubMed ID: 36288891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
    Schmidt T; Nienhüser H; Kuna C; Klose J; Strowitzki MJ; Büchler MW; Ulrich A; Schneider M
    Eur J Surg Oncol; 2018 Oct; 44(10):1610-1618. PubMed ID: 30115500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
    Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
    World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases.
    Paredes AZ; Hyer JM; Tsilimigras DI; Moro A; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Makris EA; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
    Ann Surg Oncol; 2020 Dec; 27(13):5139-5147. PubMed ID: 32779049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic versus open liver resection for colorectal liver metastases: A systematic review and meta-analysis of studies with propensity score-based analysis.
    Zhang XL; Liu RF; Zhang D; Zhang YS; Wang T
    Int J Surg; 2017 Aug; 44():191-203. PubMed ID: 28583897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.
    Chen Y; Chang W; Ren L; Chen J; Tang W; Liu T; Jian M; Liu Y; Wei Y; Xu J
    Oncologist; 2020 Jul; 25(7):e1031-e1041. PubMed ID: 32181531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.